Table Info

Table 3.

Hemodynamic and right ventricular echocardiographic data according to TAPSE/sPAP and to the degree of TR

Hemodynamic and echo parameters	TAPSE/sPAP ≤ 0.32			TAPSE/sPAP > 0.32
Hemodynamic and echo parameters	Moderate/Severe TR N = 5	Mild or no TR N = 9	p value	Moderate/Severe TR N = 4	Mild or no TR N = 12	p value
CI, L/min/m²	2.37 (1.73–2.54)	2.28 (1.69–2.28)	0.593	2.63 (2.38–2.76)	2.30 (1.89–2.59)	0.599
SVi, mL/beat/m²	30 (27–34)	30 (24–35)	0.894	34 (33–36)	36 (34–48)	0.541
GWI, mmHg%	450 (241–482)	677 (444–772)	0.240	710 (522–809)	535 (265–634)	0.316
GWE, %	78 (76–83)	87 (86–94)	0.033	92 (91–92)	96 (96–97)	0.013
GWW, mmHg%	174 (137–209)	103 (89–123)	0.029	81 (64–85)	23 (16–27)	0.101
GCW, mmHg%	680 (538–719)	1,009 (681–1,020)	0.350	873 (612–989)	649 (411–809)	0.363

TR: tricuspid regurgitation; TAPSE: tricuspid annular plane systolic excursion; sPAP: systolic pulmonary artery pressure; CI: cardiac index; SVi: stroke volume index; GWI: global work index; GWE: global work efficiency; GWW: global wasted work; GCW: global constructive work

Supplementary materials

The supplementary materials for this article are available at: https://www.explorationpub.com/uploads/Article/file/101252_sup_1.pdf.

Declarations

Author contributions

MA: Conceptualization, Investigation, Writing—original draft, Writing—review & editing. CDL, LS, SS, AG, AT, GT, CS, BP: Data curation, Investigation, Writing—review & editing. CK: Formal analysis. SG: Conceptualization, Validation, Writing—review & editing, Supervision. All authors read and approved the submitted version.

Conflicts of interest

The authors declare that they have no conflicts of interest.

Ethical approval

The study complies with the Declaration of Helsinki. Ethical approval for this study is not required as this is a retrospective study.

Consent to participate

Consent to participate in this study is not required as this is a retrospective study.

Consent to publication

Not applicable.

Availability of data and materials

The data of this manuscript could be available from the corresponding authors upon reasonable request.

Funding

Not applicable.

Copyright

Publisher’s note

Open Exploration maintains a neutral stance on jurisdictional claims in published institutional affiliations and maps. All opinions expressed in this article are the personal views of the author(s) and do not represent the stance of the editorial team or the publisher.

References

Ghio S, Guazzi M, Scardovi AB, Klersy C, Clemenza F, Carluccio E, et al. Different correlates but similar prognostic implications for right ventricular dysfunction in heart failure patients with reduced or preserved ejection fraction. Eur J Heart Fail. 2017;19:873–9. [DOI] [PubMed]

Grant ADM, Smedira NG, Starling RC, Marwick TH. Independent and incremental role of quantitative right ventricular evaluation for the prediction of right ventricular failure after left ventricular assist device implantation. J Am Coll Cardiol. 2012;60:521–8. [DOI] [PubMed]

Vonk-Noordegraaf A, Haddad F, Chin KM, Forfia PR, Kawut SM, Lumens J, et al. Right heart adaptation to pulmonary arterial hypertension: physiology and pathobiology. J Am Coll Cardiol. 2013;62:D22–33. [DOI] [PubMed]

Harrison A, Hatton N, Ryan JJ. The right ventricle under pressure: evaluating the adaptive and maladaptive changes in the right ventricle in pulmonary arterial hypertension using echocardiography (2013 Grover Conference series). Pulm Circ. 2015;5:29–47. [DOI] [PubMed] [PMC]

Benfari G, Antoine C, Miller WL, Thapa P, Topilsky Y, Rossi A, et al. Excess Mortality Associated With Functional Tricuspid Regurgitation Complicating Heart Failure With Reduced Ejection Fraction. Circulation. 2019;140:196–206. [DOI] [PubMed]

Ghio S, Mercurio V, Fortuni F, Forfia PR, Gall H, Ghofrani A, et al. A comprehensive echocardiographic method for risk stratification in pulmonary arterial hypertension. Eur Respir J. 2020;56:2000513. [DOI] [PubMed]

Ghio S, Badagliacca R, Acquaro M, Filomena D, Recchioni T, Papa S, et al. Prognostic value of deep echocardiographic phenotyping in pulmonary arterial hypertension. ERJ Open Res. 2024;10:00587–2023. [DOI] [PubMed] [PMC]

Yoshida K, Axelsen JB, Saku K, Andersen A, Man FSd, Sunagawa K, et al. How to incorporate tricuspid regurgitation in right ventricular-pulmonary arterial coupling. J Appl Physiol. 2023;135:53–9.

Russell K, Eriksen M, Aaberge L, Wilhelmsen N, Skulstad H, Remme EW, et al. A novel clinical method for quantification of regional left ventricular pressure–strain loop area: a non-invasive index of myocardial work. Eur Heart J. 2012;33:724–33. [DOI] [PubMed] [PMC]

10.

Mahdiui ME, Bijl Pvd, Abou R, Marsan NA, Delgado V, Bax JJ. Global Left Ventricular Myocardial Work Efficiency in Healthy Individuals and Patients with Cardiovascular Disease. J Am Soc Echocardiogr. 2019;32:1120–7. [DOI] [PubMed]

11.

Chan J, Edwards NFA, Khandheria BK, Shiino K, Sabapathy S, Anderson B, et al. A new approach to assess myocardial work by non-invasive left ventricular pressure–strain relations in hypertension and dilated cardiomyopathy. Eur Heart J Cardiovasc Imaging. 2019;20:31–9. [DOI] [PubMed]

12.

Butcher SC, Fortuni F, Montero-Cabezas JM, Abou R, Mahdiui ME, Bijl Pvd, et al. Right ventricular myocardial work: proof-of-concept for non-invasive assessment of right ventricular function. Eur Heart J Cardiovasc Imaging. 2021;22:142–52. [DOI] [PubMed]

13.

Richter MJ, Douschan P, Fortuni F, Gall H, Ghofrani HA, Keranov S, et al. Echocardiographic pressure–strain loop-derived stroke work of the right ventricle: validation against the gold standard. ESC Heart Fail. 2023;10:3209–15. [DOI] [PubMed] [PMC]

14.

Guazzi M, Bandera F, Pelissero G, Castelvecchio S, Menicanti L, Ghio S, et al. Tricuspid annular plane systolic excursion and pulmonary arterial systolic pressure relationship in heart failure: an index of right ventricular contractile function and prognosis. Am J Physiol Heart Circ Physiol. 2013;305:H1373–81. [DOI] [PubMed]

15.

Lanzarini L, Fontana A, Lucca E, Campana C, Klersy C. Noninvasive estimation of both systolic and diastolic pulmonary artery pressure from Doppler analysis of tricuspid regurgitant velocity spectrum in patients with chronic heart failure. Am Heart J. 2002;144:1087–94. [DOI] [PubMed]

16.

Rudski LG, Lai WW, Afilalo J, Hua L, Handschumacher MD, Chandrasekaran K, et al. Guidelines for the echocardiographic assessment of the right heart in adults: a report from the American Society of Echocardiography. Endorsed by the European Association of Echocardiography, a registered branch of the European Society of Cardiology, and the Canadian Society of Echocardiography. J Am Soc Echocardiogr. 2010;23:685–713: quiz 786. [DOI] [PubMed]

17.

Suga H, Sagawa K, Shoukas AA. Load independence of the instantaneous pressure-volume ratio of the canine left ventricle and effects of epinephrine and heart rate on the ratio. Circ Res. 1973;32:314–22. [DOI] [PubMed]

18.

Paluszkiewicz L, Börgermann J. The value of echocardiographic examination in predicting right ventricular heart failure in patients after the implantation of continuous-flow left ventricular assist devices. Interact Cardiovasc Thorac Surg. 2018;27:931–7. [DOI] [PubMed]

19.

D'Alonzo GE, Barst RJ, Ayres SM, Bergofsky EH, Brundage BH, Detre KM, et al. Survival in patients with primary pulmonary hypertension: Results from a national prospective registry. Ann Intern Med. 1991;115:343–9. [DOI] [PubMed]

20.

Hoeper MM, Pausch C, Olsson KM, Huscher D, Pittrow D, Grünig E, et al. COMPERA 2.0: a refined four-stratum risk assessment model for pulmonary arterial hypertension. Eur Respir J. 2022;60:2102311. [DOI] [PubMed] [PMC]

21.

Burkhoff D, Mirsky I, Suga H. Assessment of systolic and diastolic ventricular properties via pressure-volume analysis: a guide for clinical, translational, and basic researchers. Am J Physiol Heart Circ Physiol. 2005;289:H501–12. [DOI] [PubMed]

22.

Humbert M, Kovacs G, Hoeper MM, Badagliacca R, Berger RMF, Brida M, et al.; ESC/ERS Scientific Document Group. 2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: Developed by the task force for the diagnosis and treatment of pulmonary hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS). Endorsed by the International Society for Heart and Lung Transplantation (ISHLT) and the European Reference Network on rare respiratory diseases (ERN-LUNG). Eur Heart J. 2022;43:3618–731. [DOI] [PubMed]